Get the Stockscreener App
1.10
0.90%
-0.01
Pre-market:
1.13
0.03
+2.73%
Heron Therapeutics Inc stock is traded at $1.10, with a volume of 1.10M.
It is down -0.90% in the last 24 hours and down -16.67% over the past month.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
See More
Previous Close:
$1.11
Open:
$1.11
24h Volume:
1.10M
Relative Volume:
0.65
Market Cap:
$201.65M
Revenue:
$137.74M
Net Income/Loss:
$-27.97M
P/E Ratio:
-6.875
EPS:
-0.16
Net Cash Flow:
$-9.61M
1W Performance:
+0.00%
1M Performance:
-16.67%
6M Performance:
-36.05%
1Y Performance:
-11.29%
1-Day Range:
$1.10
$1.12
1-Week Range:
$1.08
$1.16
52-Week Range:
$1.05
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
Name
Heron Therapeutics Inc
Sector
Industry
Phone
(858) 251-4400
Address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Compare HRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.10 | 203.53M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-25 | Initiated | H.C. Wainwright | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-23-24 | Initiated | CapitalOne | Overweight |
| Mar-13-24 | Reiterated | Needham | Buy |
| May-27-20 | Initiated | Guggenheim | Buy |
| Feb-20-20 | Reiterated | Needham | Buy |
| Jan-16-19 | Reiterated | Needham | Buy |
| Apr-05-18 | Initiated | Evercore ISI | Outperform |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Mar-01-18 | Reiterated | Needham | Buy |
| Jan-03-18 | Initiated | Leerink Partners | Outperform |
| Sep-27-17 | Initiated | Northland Capital | Outperform |
| Feb-27-17 | Initiated | Needham | Buy |
| Oct-26-16 | Initiated | Aegis Capital | Buy |
| Sep-06-16 | Resumed | Lake Street | Buy |
| May-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Dec-10-15 | Initiated | Lake Street | Buy |
| Sep-23-15 | Reiterated | Leerink Partners | Outperform |
| Sep-02-15 | Initiated | BofA/Merrill | Buy |
| Aug-03-15 | Reiterated | Brean Capital | Buy |
| Jun-30-15 | Reiterated | JMP Securities | Mkt Outperform |
| Jun-19-15 | Reiterated | Leerink Partners | Outperform |
| Aug-07-14 | Initiated | Noble Financial | Buy |
View All
Heron Therapeutics Inc Stock (HRTX) Latest News
How cyclical is Heron Therapeutics Inc. (AXD2) stock compared to rivalsEntry Point & Entry Point Confirmation Alerts - newser.com
Is Heron Therapeutics Inc. (AXD2) stock prepared for digital transition2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
Tools to monitor Heron Therapeutics Inc. recovery probability2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Ranking Heron Therapeutics Inc. among high performing stocks via toolsMarket Movement Recap & High Conviction Buy Zone Alerts - newser.com
Can Heron Therapeutics Inc. recover in the next quarterQuarterly Profit Review & Community Verified Swing Trade Signals - newser.com
Sentiment analysis tools applied to Heron Therapeutics Inc.2025 Market Sentiment & Weekly Stock Breakout Alerts - newser.com
Can Heron Therapeutics Inc. (AXD2) stock deliver consistent EPS growthJuly 2025 Earnings & Verified High Yield Trade Plans - newser.com
Will Heron Therapeutics Inc. stock attract more institutional investorsJuly 2025 WrapUp & Fast Gain Stock Tips - newser.com
Heron Therapeutics Inc. stock daily chart insightsGDP Growth & Weekly High Conviction Trade Ideas - newser.com
Will Heron Therapeutics Inc. stock benefit from automationJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
Heron Therapeutics Inc. stock prediction for this weekJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
What MACD and RSI say about Heron Therapeutics Inc.Portfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
Can Heron Therapeutics Inc. stock weather global recession2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com
Is Heron Therapeutics Inc. (AXD2) stock inflation resilientQuarterly Earnings Report & High Conviction Buy Zone Alerts - newser.com
What drives Sotherly Hotels Inc stock priceEarnings Forecast Updates & Avoid Market Traps With Pro-Level Warnings - earlytimes.in
What analysts say about Heron Therapeutics Inc AXD2 stockMorning Star Patterns & Turn Market Volatility into Wealth - earlytimes.in
Can trapped investors hope for a rebound in Heron Therapeutics Inc.2025 Price Action Summary & Expert Curated Trade Ideas - newser.com
Why Heron Therapeutics Inc. (AXD2) stock could rally stronglyJuly 2025 Institutional & Technical Buy Zone Confirmation - newser.com
What analyst consensus says on Heron Therapeutics Inc. stockJuly 2025 Outlook & Long Hold Capital Preservation Plans - newser.com
Detecting price anomalies in Heron Therapeutics Inc. with AIWeekly Gains Report & Free Community Consensus Stock Picks - newser.com
Heron Therapeutics Inc. stock chart pattern explained2025 Top Gainers & Technical Pattern Alert System - newser.com
What is Northland Capmk's Estimate for HRTX FY2026 Earnings? - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported, And Analysts Assigned A US$4.50 Price Target - simplywall.st
[Form 3] HERON THERAPEUTICS, INC. /DE/ Initial Statement of Beneficial Ownership - Stock Titan
What is HC Wainwright's Forecast for HRTX FY2025 Earnings? - MarketBeat
Heron Therapeutics Inc Stock (HRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):